Who owns Adaptive Biotechnologies (ADPT)? Superinvestor holders
3 superinvestors of the 157 tracked here hold Adaptive Biotechnologies (ADPT) in their latest 13F filing, with $702.9M between them. Andreas Halvorsen gives it the most weight: 1.83% of the reported portfolio. In their latest reported quarter, Polen Capital team added; Cathie Wood reduced.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Andreas Halvorsen, $643.4M
- Largest weight
- Andreas Halvorsen, 1.83%of their portfolio
- Combined value
- $702.9M
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Andreas HalvorsenViking Global Investors | 1.83% | $643.4M | 29.99M | No change | 0 | Q2 2026 |
| 2 | Cathie WoodARK Invest | 0.32% | $55.5M | 1.92M | ▼ Reduced 8.1% | −169.52K | Q3 2026 |
| 3 | Polen Capital teamPolen Capital Management | 0.04% | $4.1M | 140.17K | ▲ Added 37% | +37.71K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 2.06M | $59.6M | 1 | 1 |
| Q2 2026 | 157 | 3 | 32.19M | $690.4M | 0 | 2 |
| Q1 2026 | 157 | 3 | 32.2M | $447M | 0 | 2 |
| Q4 2025 | 157 | 4 | 32.47M | $527.3M | 2 | 1 |
| Q3 2025 | 157 | 3 | 33.45M | $500.4M | 1 | 1 |
| Q2 2025 | 157 | 3 | 34.15M | $397.9M | 1 | 1 |
| Q1 2025 | 156 | 2 | 37.73M | $280.3M | 0 | 1 |
| Q4 2024 | 156 | 2 | 39.42M | $236.3M | 0 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 1.92M | 2.09M | 2.09M | 2.14M | 3.17M | 4.02M | 7.73M | 9.42M |
| Polen Capital team | 140.17K | 102.46K | 116.05K | 325.77K | 291.2K | 142.26K | — | — |
| Andreas Halvorsen | · | 29.99M | 29.99M | 29.99M | 29.99M | 29.99M | 29.99M | 29.99M |
| Andrew Spokes | — | — | — | 11K | — | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own ADPT?
In their latest 13F filings: Andreas Halvorsen (1.83% of the portfolio, $643.4M), Cathie Wood (0.32% of the portfolio, $55.5M), Polen Capital team (0.04% of the portfolio, $4.1M).
Who bought ADPT last quarter?
Polen Capital team (added 37%). “Last quarter” is each investor's latest reported quarter.
Who sold ADPT last quarter?
Reduced: Cathie Wood (8.1% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Adaptive Biotechnologies (ADPT)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/ADPT/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to ADPT by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.